Updated Comprehensive Patent Search Reports by GenericsWeb Now Available at MarketPublishers.com29 Sep 2011 • by Natalie Aster
LONDON - Market Publishers Ltd informs that updated comprehensive GenericsWeb patent search reports covering various types of insulin have been added to its catalogue.
Insulin Glargine - Comprehensive patent search. Insulin glargine is used for treatment of type 1 and type 2 diabetes mellitus for the control of hyperglycaemia. The study presents comprehensive patent searching on insulin glargine, covering the world's key territories. The pipeline developer report not only identifies relevant patents, covering molecule, formulation, process, use, combination and assay techniques, but also features categorization and interpretation, all delivered by a convenient online interface. Manual filtration of patents not relevant to generic development is also provided …
Insulin Lispro - Comprehensive patent search. The fast-acting type of insulin – insulin lispro – is used for treatment of diabetes mellitus, optionally in combination with longer-acting insulin for type 1 diabetes or in a combination therapy with a sulfonylurea agent for type 2 diabetes. The pipeline developer report covers insulin lispro, identifying relevant patents, offering the full-scale data on the patent including categorization and interpretation. Grouping by patent family and interpretation of key aspects of the patent claims; filtration of patents not relevant to generic development; changes to patent families and statuses, and more can also be found in the study …
More updated and new publisher’s pipeline reports can be found at Genericsweb page.
The Market Publishers, Ltd.
Tel: +44 208 123 2220
Fax: +44 207 900 3970